CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026

Phase 3LEAP-001lenvatinib
Related Companies

Read the original article

Published by PR Newswire Biotech on October 15, 2026 12:08 PM

Read Original